Cargando…

Molecular Tumor Board Review and Improved Overall Survival in Non–Small-Cell Lung Cancer

With the introduction of precision medicine, treatment options for non–small-cell lung cancer have improved dramatically; however, underutilization, especially in disadvantaged patients, like those living in rural Appalachian regions, is associated with poorer survival. Molecular tumor boards (MTBs)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Bin, Chen, Quan, Allison, Derek, El Khouli, Riham, Peh, Keng Hee, Mobley, James, Anderson, Abigail, Durbin, Eric B., Goodin, Donald, Villano, John L., Miller, Rachel W., Arnold, Susanne M., Kolesar, Jill M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2021
Materias:	ORIGINAL REPORTS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492377/ https://www.ncbi.nlm.nih.gov/pubmed/34622117 http://dx.doi.org/10.1200/PO.21.00210

Ejemplares similares

Molecular Tumor Board–Assisted Care in an Advanced Cancer Population: Results of a Phase II Clinical Trial
por: Miller, Rachel W., et al.
Publicado: (2022)

Association of first primary cancer with risk of subsequent primary cancer among survivors of adult-onset cancers in Kentucky and Appalachian Kentucky
por: Chen, Quan, et al.
Publicado: (2023)

Macrophage Repolarization as a Therapeutic Strategy for Osteosarcoma
por: Anand, Namrata, et al.
Publicado: (2023)

Clinical Outcomes of Molecular Tumor Boards: A Systematic Review
por: Larson, Kara L., et al.
Publicado: (2021)

Case report: A unique presentation of a high-grade neuroepithelial tumor with EWSR1::PATZ1 fusion with diagnostic, molecular, and therapeutic insights
por: Ene, Andre, et al.
Publicado: (2023)

Real world clinicopathologic observations of patients with metastatic solid tumors receiving immune checkpoint inhibitor therapy: Analysis from Kentucky Cancer Registry
por: Jacob, Aasems, et al.
Publicado: (2021)

Real-World Evaluation of Universal Germline Screening for Cancer Treatment-Relevant Pharmacogenes
por: Hutchcraft, Megan L., et al.
Publicado: (2021)

EGFR testing and erlotinib use in non-small cell lung cancer patients in Kentucky
por: Larson, Kara L., et al.
Publicado: (2020)

Next Generation Sequencing and Molecular Biomarkers in Ovarian Cancer—An Opportunity for Targeted Therapy
por: Harbin, Laura M., et al.
Publicado: (2022)

Prevalence of SARS-CoV-2 IgG antibodies in health care workers at a tertiary care academic medical center – An assessment of occupational infection risk
por: Forster, Derek, et al.
Publicado: (2021)

Immune checkpoint inhibitors in large cell neuroendocrine carcinoma: current status
por: Chauhan, Aman, et al.
Publicado: (2018)

Olaparib Combined with an ATR or Chk1 Inhibitor as a Treatment Strategy for Acquired Olaparib-Resistant BRCA1 Mutant Ovarian Cells
por: Burgess, Brian T., et al.
Publicado: (2020)

Radiopharmaceutical Validation for Clinical Use
por: Kunos, Charles A., et al.
Publicado: (2021)

Gynecologic large cell neuroendocrine carcinoma: A review
por: Burkeen, Grant, et al.
Publicado: (2020)

A single arm phase II study of bone-targeted Sn-117 m-DTPA in symptomatic castration-resistant prostate cancer with skeletal metastases
por: Myint, Zin W., et al.
Publicado: (2022)

Prioritization of family member sequencing for the detection of rare variants
por: Sippy, Rachel, et al.
Publicado: (2016)

Editorial: Anticancer Potential of Artemisia annua
por: Kolesar, Jill M., et al.
Publicado: (2022)

Amyloid-PET and White Matter Hyperintensities Have Independent Effects on Baseline Cognitive Function and Synergistic Effects on Longitudinal Executive Function
por: Ali, Doaa G., et al.
Publicado: (2023)

White matter hyperintensities influence distal cortical β‐amyloid accumulation in default mode network pathways
por: Ali, Doaa G., et al.
Publicado: (2023)

Multiparametric deep learning tissue signatures for a radiological biomarker of breast cancer: Preliminary results
por: Parekh, Vishwa S., et al.
Publicado: (2019)

Integration of liquid biopsy and pharmacogenomics for precision therapy of EGFR mutant and resistant lung cancers
por: Kolesar, Jill, et al.
Publicado: (2022)

Use of large pieces of printed circuit boards for bioleaching to avoid ‘precipitate contamination problem’ and to simplify overall metal recovery
por: Adhapure, N.N., et al.
Publicado: (2014)

Integrated Multiparametric Radiomics and Informatics System for Characterizing Breast Tumor Characteristics with the OncotypeDX Gene Assay
por: Jacobs, Michael A., et al.
Publicado: (2020)

“Get to Know Me” Board
por: Gajic, Ognjen, et al.
Publicado: (2019)

Clostridium difficile infection perceptions and practices: a multicenter qualitative study in South Africa
por: Legenza, Laurel, et al.
Publicado: (2018)

CCNE1 Amplification as a Predictive Biomarker of Chemotherapy Resistance in Epithelial Ovarian Cancer
por: Gorski, Justin W., et al.
Publicado: (2020)

MUTYH as an Emerging Predictive Biomarker in Ovarian Cancer
por: Hutchcraft, Megan L., et al.
Publicado: (2021)

Post FDA approval analysis of 200 gallium-68 DOTATATE imaging: A retrospective analysis in neuroendocrine tumor patients
por: Chauhan, Aman, et al.
Publicado: (2020)

A Phase I Dose Escalation and Expansion Study of Epidiolex (Cannabidiol) in Patients with Biochemically Recurrent Prostate Cancer
por: Myint, Zin W., et al.
Publicado: (2023)

hPG(80) (Circulating Progastrin), a Novel Blood-Based Biomarker for Detection of Poorly Differentiated Neuroendocrine Carcinoma and Well Differentiated Neuroendocrine Tumors
por: Chauhan, Aman, et al.
Publicado: (2022)

Developmental Evaluation of an Established Advisory Board
por: Lessem, Rachel
Publicado: (2020)

The Board of Supervision
por: Strachan, John M.
Publicado: (1857)

Specific mutations in KRAS codon 12 are associated with worse overall survival in patients with advanced and recurrent colorectal cancer
por: Jones, Robert P, et al.
Publicado: (2017)

SYNE1 Mutation Is Associated with Increased Tumor Mutation Burden and Immune Cell Infiltration in Ovarian Cancer
por: Harbin, Laura M., et al.
Publicado: (2023)

Human macrophage-engineered vesicles for utilization in ovarian cancer treatment
por: Schweer, David, et al.
Publicado: (2023)

Biliary tract large cell neuroendocrine carcinoma: current evidence
por: Raiker, Riva, et al.
Publicado: (2019)

Direct delivery of an investigational cell therapy in patients with Parkinson’s disease: an interim analysis of feasibility and safety of an open-label study using DBS-Plus clinical trial design
por: Quintero, Jorge E, et al.
Publicado: (2022)

The DCS board: an autonomous single-board computer
Publicado: (2004)

Implementation of Nurse Navigation Improves Rate of Molecular Tumor Testing for Ovarian Cancer in a Gynecologic Oncology Practice
por: Rives, Taylor A., et al.
Publicado: (2023)

Feasibility of Using a Commercial Board Game to Assess Upper Extremity Function in Older Adults
por: Niemiec, Allison, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u9ornd9849vllpvk7doaasligo